Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy

Virotherapy on the basis of oncolytic vaccinia virus (VACV) strains is a novel approach for canine cancer therapy. Here we describe, for the first time, the characterization and the use of VACV strain GLV-5b451 expressing the anti-vascular endothelial growth factor (VEGF) single-chain antibody (scAb...

詳細記述

保存先:
書誌詳細
出版年:Viruses
主要な著者: Adelfinger, Marion, Bessler, Simon, Frentzen, Alexa, Cecil, Alexander, Langbein-Laugwitz, Johanna, Gentschev, Ivaylo, Szalay, Aladar A.
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2015
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4517140/
https://ncbi.nlm.nih.gov/pubmed/26205404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v7072811
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料